Team

Two physicians who follow these patients, an engineer who has built impedance systems, and a product lead who has done the regulatory work before.

• Adam Hofmann, MD, FRCPCCo-founder and Chief Executive OfficerGeneral internist. Leads strategy, regulatory, fundraising, and partnerships.
• Guillaume Gibeau, MDCo-founder; Principal InvestigatorCardiologist, CISSS des Laurentides. Leads clinical study design and execution.
• Shania Tubana-DeanCo-founder; Product and Regulatory LeadLead author of the 2025 systematic review. Owns the quality management system and regulatory submissions.
• Emily Porter, PhDEngineering Advisor (consulting)Advises on the design, testing, and validation of impedance-based measurement technologies.
• Thomas CoadyEngineering Lead, Quality and SafetyLeads hardware and firmware engineering and electrical safety compliance.

Advisors and counsel

Regulatory advisor: Tal Bresler-Stramer, PhD, OrbitRA Regulatory Consulting. Corporate and intellectual property counsel: Renno & Co., Toronto. Program support: Life Sciences Central (MaRS Discovery District, OBIO, and Toronto Innovation Acceleration Partners).